Clinical trial

Combination Chemotherapy Before and After Surgery in Treating Patients With…

NCT00019864 · National Cancer Institute (NCI), NIH · Terminated

Key facts

NCT number NCT00019864
Title Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
Official title Osteosarcoma: Outcome of Therapy Based on Histologic Response. A Collaborative Effort of the POB/NCI, Texas Children's Hospital and University of Oklahoma.
Lead sponsor National Cancer Institute (NCI), NIH
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Cardiac Toxicity, Sarcoma
Intervention type Biological, Drug, Procedure
Interventions filgrastim, cisplatin, dexrazoxane hydrochloride, doxorubicin hydrochloride, leucovorin calcium, methotrexate, adjuvant therapy, conventional surgery, neoadjuvant therapy
Enrollment 100
Start date Mar 1, 2000
Primary completion Dec 1, 2006
Completion Oct 1, 2011
First posted Jan 27, 2003
Last update posted Jun 8, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies